Lo provo per voi. Rilassare corpo e mente con l’olio CBD full spectrum

BIBLIOGRAFIA

1. Changes in Cannabis Potency Over the Last 2 Decades (1995-2014): Analysis of Current Data in the United States.ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC.Biol Psychiatry. 2016 Apr
2. Cannabis-based medicines for chronic neuropathic pain in adults.Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W.Cochrane Database Syst Rev. 2018 Mar
3. Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.Bilbao A, Spanagel R.BMC Med. 2022 Aug 19
4. Industrial Hemp (Cannabis sativa subsp. sativa) as an Emerging Source for Value-Added Functional Food Ingredients and Nutraceuticals.Rupasinghe HPV, Davis A, Kumar SK, Murray B, Zheljazkov VD.Molecules. 2020 Sep
5. Cannabidiol Content and In Vitro Biological Activities of Commercial Cannabidiol Oils and Hemp Seed Oils.Kitamura M, Kiba Y, Suzuki R, Tomida N, Uwaya A, Isami F, Deng S.Medicines (Basel). 2020 Sep
6. The endocannabinoid system: an emerging key player in inflammation.Witkamp R, Meijerink J.Curr Opin Clin Nutr Metab Care. 2014 Mar
7. Endocannabinoid system acts as a regulator of immune homeostasis in the gut.Acharya N, Penukonda S, Shcheglova T, Hagymasi AT, Basu S, Srivastava PK.Proc Natl Acad Sci U S A. 2017 May
8. Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation.Bluett RJ, Gamble-George JC, Hermanson DJ, Hartley ND, Marnett LJ, Patel S.Transl Psychiatry. 2014 Jul
9. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It’s Been ….Baron EP.Headache. 2015 Jun
10. Distribution of cannabinoid receptors in the central and peripheral nervous system.Mackie K.Handb Exp Pharmacol. 2005
11. Clinicians’ Guide to Cannabidiol and Hemp Oils.VanDolah HJ, Bauer BA, Mauck KF.Mayo Clin Proc. 2019 Sep
12. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.Legare CA, Raup-Konsavage WM, Vrana KE.Pharmacology. 2022
13. Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series.Mazza M.J Cannabis Res. 2021 Feb
14. Cannabidiol (CBD) and Δ⁹-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial.Suraev A, Grunstein RR, Marshall NS, D’Rozario AL, Gordon CJ, Bartlett DJ, Wong K, Yee BJ, Vandrey R, Irwin C, Arnold JC, McGregor IS, Hoyos CM.BMJ Open. 2020 May
15. A Hemp oil, CBD, and Marijuana Primer: Powerful Pain, Insomnia, and Anxiety-relieving Tools!Teitelbaum J.Altern Ther Health Med. 2019 Jun
16. Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study.Spinella TC, Stewart SH, Naugler J, Yakovenko I, Barrett SP.Psychopharmacology (Berl). 2021 Jul
17. Cannabis and Vulvodynia Symptoms: A Preliminary Report.Barach E, Slavin MN, Earleywine M.Cannabis. 2020 Jul
18. Medical Cannabis for Gynecologic Pain Conditions: A Systematic Review.Liang AL, Gingher EL, Coleman JS.Obstet Gynecol. 2022 Feb
19. Immune Responses Regulated by Cannabidiol.Nichols JM, Kaplan BLF.Cannabis Cannabinoid Res. 2020 Feb 
20. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination.Robaina Cabrera CL, Keir-Rudman S, Horniman N, Clarkson N, Page C.Pulm Pharmacol Ther. 2021 Aug
21. Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview P Kumar, 2021
22. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Russo EB.Br J Pharmacol. 2011 Aug
23. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S, Schmidlkofer S, Westwood M, Kleijnen J.JAMA. 2015 Jun